Work

Oxidative Stress in Idiopathic Non-Obstructive Azoospermia: Evidence, Measurement Constraints, and Implications for Antioxidant Pretreatment

Year: 2026
Type: article
Abstract: Idiopathic non-obstructive azoospermia (iNOA) is heterogeneous and lacks established redox-directed treatment to improve sperm retrieval. This critical narrative review evaluates causal interpretation, biomarker validity, and antioxidant pretreatment. PubMed, Embase, Scopus, Web of Science, ClinicalTrials.gov, the World Health Organization registry platform, and ISRCTN were searched through 30 September 2026. Study-level appraisal separated population directness, measurement limitations, and outcome relevance. Most human evidence concerns mixed non-obstructive azoospermia (NOA), selected tissue phenotypes, or public datasets. Redox abnormalities accompany established spermatogenic failure, but human studies have not shown that they precede germ-cell loss. Disease associations and cell-composition effects have the strongest direct human support; an amplifier role is plausible, and a driver role is unproven. Observational melatonin exposure in 11 men was associated with tissue-marker differences, without clinical outcome data. Mechanistic, diagnostic, prognostic, and treatment-predictive evidence are distinct categories; neither preoperative redox prognosis nor treatment selection is clinically validated. No clearly eligible registry record explicitly designated sperm retrieval as the primary outcome of antioxidant pretreatment in rigorously characterized iNOA, although nonspecific endpoints and incomplete coverage limit this finding. Routine redox testing and empirical antioxidant pretreatment remain unsupported by direct clinical evidence. Progress requires reliable compartment-specific assays, independent validation, and randomized trials of sperm retrieval and safety.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236736288
FWCI:
Cites: 98
Cited by:
Related to: 10